BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1279944)

  • 1. Enhanced expression of complement regulatory proteins on thyroid epithelial cells of Graves' disease.
    Nakai H; Hirakawa S; Hayakawa N; Amano T; Ota Z
    Acta Med Okayama; 1992 Oct; 46(5):323-30. PubMed ID: 1279944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
    Tandon N; Yan SL; Morgan BP; Weetman AP
    Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells.
    Tandon N; Morgan BP; Weetman AP
    Immunology; 1992 Feb; 75(2):372-7. PubMed ID: 1372592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.
    Rooney IA; Morgan BP
    Immunology; 1990 Nov; 71(3):308-11. PubMed ID: 1702747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
    Simpson KL; Houlihan JM; Holmes CH
    Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
    Simpson KL; Holmes CH
    Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer.
    Inoue H; Mizuno M; Uesu T; Ueki T; Tsuji T
    Acta Med Okayama; 1994 Oct; 48(5):271-7. PubMed ID: 7532345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.
    Bardenstein DS; Dietz Y; Lass JH; Medof ME
    Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid follicular cell function after non-lethal complement membrane attack.
    Weetman AP; Freeman M; Morgan BP
    Clin Exp Immunol; 1990 Oct; 82(1):69-74. PubMed ID: 2170066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
    Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
    Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.
    Rooney IA; Davies A; Morgan BP
    Immunology; 1992 Mar; 75(3):499-506. PubMed ID: 1374057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa.
    Cervoni F; Oglesby TJ; FĂ©nichel P; Dohr G; Rossi B; Atkinson JP; Hsi BL
    J Immunol; 1993 Jul; 151(2):939-48. PubMed ID: 7687624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles.
    Lampert IA; Schofield JB; Amlot P; Van Noorden S
    J Pathol; 1993 Jun; 170(2):115-20. PubMed ID: 7688416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.